PharmaOnco™ Human Immune Genome Editing Mouse Model, hCD47 (CAT#: ITS-1123-HM20)

This model aims to reduce anemia in in myeloid-enhanced mice and study the cytotoxicity of anti-CD47 antibodies by humanizing the CD47 gene.

Human-specific infectious diseases; Antibody-based immune therapy; Human-specific vaccine development; Cell-based adoptiive immunity

NSG (hCD47)